Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells

Antioxidants and Redox Signaling

Volumn 3, Issue 6, 2001, Pages 969-979

  Serrero, G ^a   Lu, R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; RESVERATROL; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035659623     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601317203512     Document Type: Article

References (56)

1. Dietary phytoestrogens and cancer: In vitro and in vivo studies
2. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol
3. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: Evidence for negative autocrine regulation by transforming growth factor beta
4. Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains
5. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta
6. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
7. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment
8. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
9. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast
10. Potent inhibitory action of red wine polyphenols on human breast cancer cells
11. Influence of fosetyl-AL on phytoalexin accumulation in the plasmopara viticola-grapevine interaction
12. Stimulatory and inhibitory growth factors and breast cancer
13. Growth factors in breast cancer
14. Anticancer action of cube insecticide: Correlation for rotenoid constituents between inhibition of NADH: Ubiquinone oxidoreductase and induced ornithine decarboxylase activities
15. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
16. Inhibition of human LDL oxidation by resveratrol
17. Biological effects of resveratrol
18. Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging
19. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
20. Mortality associated with moderate intakes of wine, beer, or spirits
21. Metastatic lesions from prostate cancer do not express estrogen and progesterone receptors
22. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
23. Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells
24. Insulin-like growth factors and their binding proteins: Biological actions
25. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
26. Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells
27. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen
28. Mechanisms of growth control in normal and malignant breast epithelial
29. Growth regulatory peptide production by human breast carcinoma cells
30. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
31. Resveratrol, a natural product from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
32. Stimulation of PC cell derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast carcinoma cell line MCF-7
33. Inhibition of PC-cell derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468
34. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 by PC-cell-derived growth factor (PCDGF/granulin precursor)
35. Phytoestrogens are partial estrogen agonists in the adult male mouse
36. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats
37. Estrogen regulated messenger RNAs in human breast cancer cells
38. Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines
39. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
40. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines
41. Insulin-like growth factor expression in human cancer cell lines
42. Sister chromatid exchanges and proliferation kinetics of human metastatic breast tumor cell lines
43. Comparative study of human and rat mammary tumorigenesis
44. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells
45. Resveratrol; a molecule whose time has come? and gone?
46. Delayed mammary tumor progression in Muc-1 null mice
47. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells
48. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
49. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
50. Resveratrol induced Fas signalling-independent apoptosis in THP-1 human monocytic leukemia cells
51. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells
52. Insulin-like growth factor II mRNA expression in human breast cancer
53. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines